Investors Warned At Morgan Stanley Dinner About Stealth Drug Price ControlsMark Melin
Watch out for government to take a “back door” approach to stealth drug price controls. Such was the topic recently discussed at a Morgan Stanley dinner and put in report form, which was reviewed by ValueWalk. Political rancor regarding a single payer system or overt price controls are likely to be a smokescreen to pressure the back door solution, those attending the March 23 dinner were told. Plus there is the “threat” of a little known payment committee, the “death panel,” that could come into play. The report . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.